Parallax Volatility Advisers’s Accelerate Diagnostics AXDX Stock Holding History

Parallax Volatility Advisers’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,084	Closed	-$161K	–	2903
2018 Q3	$249K	Sell	1,084 -1,592	-59%	-$352K	﹤0.01%	1573
2018 Q2	$597K	Buy	2,676 +1,749	+189%	+$391K	﹤0.01%	1224
2018 Q1	$212K	Buy	927 +528	+132%	+$139K	﹤0.01%	1239
2017 Q4	$105K	Buy	+399	New	+$93.5K	﹤0.01%	2773
2017 Q3	–	Sell	-2,596	Closed	-$638K	–	2080
2017 Q2	$710K	Buy	+2,596	New	+$704K	﹤0.01%	1134

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Parallax Volatility Advisers's AXDX Position: Q4 2018 in Review

Parallax Volatility Advisers sold out of Accelerate Diagnostics (AXDX) in Q4 2018, closing a stake of 1,084 shares — an estimated $161K sold.

Parallax Volatility Advisers first reported a position in AXDX in Q2 2017 and held it in 5 quarters. The position peaked at $710K in Q2 2017. 107 funds tracked by Wall St. Rank hold AXDX as of Q4 2018.

Parallax Volatility Advisers reported no remaining Accelerate Diagnostics position as of Q4 2018 after selling out during the quarter.
Parallax Volatility Advisers sold 1,084 Accelerate Diagnostics shares in Q4 2018, an estimated $161K.
Parallax Volatility Advisers first reported a position in Accelerate Diagnostics in Q2 2017 and held it in 5 quarters.
Parallax Volatility Advisers's Accelerate Diagnostics position peaked at $710K in Q2 2017.
107 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2018.

Based on Parallax Volatility Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.